A nested case-control study detected markedly increased maternal serum FABP4 levels at 8 to 13 weeks of gestation in subjects who were eventually diagnosed with preeclampsia, suggesting that FAPB4 is a potential predictive biomarker for PE [40]. The gene discussed is FABP4; the disease is preeclampsia.